Geralla, Baby Girl .
HRN: 27-43-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
AMPICILLIN 250MG (VIAL)
07/11/2025
07/17/2025
IV
145mg
2 Times A Day
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes